• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Quaker BioVentures

edit

Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the life science industry, including biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals, and healthcare services. Quaker BioVentures invests in companies at all stages of development, from early stage start-ups to public companies. Founded in 2003, the firm is currently investing Quaker BioVentures II, a $420 million fund formed in 2007. Quaker BioVentures manages over $700 million in committed capital.

Recent Milestones

edit

• 
  Quaker BioVentures invested in RainDance Technologies. (4/29/13)
  Posted 5/1/13 at 7:47pm via finsmes.com
• 
  Quaker BioVentures invested in Intact Vascular. (9/5/12)
  Posted 9/5/12 at 7:29pm via intactvascular.com
• 
  Quaker BioVentures invested in Tarsa Therapeutics. (3/16/12)
  Posted 3/16/12 at 5:50am via prnewswire.com
• 
  Quaker BioVentures invested in NovaSom. (6/27/11)
  Posted 6/27/11 at 8:15pm via novasom.com
• 
  Quaker BioVentures invested in Neuronetics. (5/16/11)
  Posted 5/20/11 at 3:32am via marketwire.com
• 
  Quaker BioVentures invested in RainDance Technologies. (1/25/11)
  Posted 1/25/11 at 8:56pm via finsmes.com
• 
  Quaker BioVentures invested in Celator Pharmaceuticals. (9/1/10)
  Posted 9/2/10 at 6:13am via celatorpharma.com
• 
  Quaker BioVentures invested in Achillion Pharmaceuticals. (8/18/10)
  Posted 10/31/10 at 6:24pm via achillion.com
• 
  Quaker BioVentures invested in TetraLogic Pharmaceuticals. (8/10/10)
  Posted 8/10/10 at 5:26pm via fiercebiotech.com
• 
  Quaker BioVentures invested in Corridor Pharmaceuticals. (6/16/10)
  Posted 7/8/10 at 7:56pm via yahoo.com
• 
  Quaker BioVentures invested in TearScience. (5/6/10)
  Posted 5/6/10 at 8:50pm via onbiovc.com
• 
  Quaker BioVentures invested in TransEnterix. (1/21/10)
  Posted 1/22/10 at 4:13am via onbiovc.com
• 
  Quaker BioVentures invested in Tarsa Therapeutics. (1/17/10)
  Posted 1/19/10 at 11:35pm via onbiovc.com
• 
  Quaker BioVentures invested in BioLeap. (1/12/10)
  Posted 1/12/10 at 6:22pm via businesswire.com
• 
  Quaker BioVentures invested in Regado Biosciences. (12/17/09)
  Posted 12/17/09 at 7:20pm via dowjones.com
• 
  Quaker BioVentures invested in Arginetix. (11/2/09)
  Posted 11/2/09 at 9:01pm via onbiovc.com

Investments

Videos

Sources

1. RainDance Technologies Closes $20M Series E Financing (finsmes.com) [edit]
2. Intact Vascular Announces $15.5 MM Series A Financing and Names Dennis Wahr, M.D. as Chairman (intactvascular.com) [edit]
3. Tarsa Therapeutics Completes $28 Million Series B Financing to Advance OSTORA™ Oral Calcitonin (prnewswire.com) [edit]
4. NovaSom Closes $35 Million in Equity Financing (novasom.com) [edit]
5. Neuronetics, Inc. Raises $30 Million in Series E Financing (marketwire.com) [edit]
6. RainDance Technologies Closes $37.5M Series D Financing Round (finsmes.com) [edit]
7. CELATOR® PHARMACEUTICALS RAISES $20 MILLION IN SERIES D FINANCING (celatorpharma.com) [edit]
8. Achillion Announces Private Placement of $50 Million (ir.achillion.com) [edit]
9. TetraLogic nabs $32M round for lead cancer therapy Read more: TetraLogic nabs $32M round for lead cancer therapy (fiercebiotech.com) [edit]
10. Arginetix and Immune Control Merge to Form Corridor Pharmaceuticals (finance.yahoo.com) [edit]
11. TearScience, Inc.: Series C $44.5M (onbiovc.com) [edit]
12. TransEnterix, Inc.: Series B $55M (onbiovc.com) [edit]
13. Tarsa Therapeutics, Inc.: Series A $24M (onbiovc.com) [edit]
14. BioLeap, Inc. Secures $5M Series A Financing from Adams Capital Management and Quaker BioVentures (eon.businesswire.com) [edit]
15. Regado Biosciences Stays Patient, Looks To Europe With New $40M (fis.dowjones.com) [edit]
16. Arginetix, Inc.: Series B $4.6M (onbiovc.com) [edit]
17. Sleep Solutions, Inc.: Series F $20M (onbiovc.com) [edit]
18. Neuronetics, Inc.: Series D $30M (onbiovc.com) [edit]
19. Rapid Micro Biosystems, Inc.: Series A $18.6M (onbiovc.com) [edit]
20. Cempra Pharmaceuticals, Inc.: Series C $46M (onbiovc.com) [edit]
21. Arginetix, Inc. Completes $2.3 Million Initial Financing and Technology License (findarticles.com) [edit]
22. Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C (mitsuiventures.com) [edit]
23. Tengion Closes $33 Million in Series C Funding Deerfield Partners Joins Investor Group as Company Advances Novel Regenerative Medicine Products (tengion.com) [edit]
24. Argolyn Bioscience Raises $15.8 Million Round of Financing (salesandmarketingnetwork.com) [edit]
25. BIOLEX THERAPEUTICS RAISES $30 MILLION TO ADVANCE ITS HEPATITIS C DRUG CANDIDATE AND OTHER PIPELINE PROGRAMS (biolex.com) [edit]
26. StageMark Completes $1.6 Million Venture Capital Financing. (allbusiness.com) [edit]
27. Tengion Inc. Completes $50 Million Series "B" Round Financing led by Bain Capital and Quaker BioVentures will support neo-bladder clinical trials, manufacturing capacity and pipeline development (tengion.com) [edit]
28. Nitric Bio received its initial funding and has raised a total of $14M (nitricbio.com) [edit]
29. BIOLEX THERAPEUTICS RAISES $36 MILLION IN VENTURE FINANCING (biolex.com) [edit]